Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
decrease risk » increased risk (Expand Search), increases risk (Expand Search), disease risk (Expand Search)
bit decrease » bfrt decreased (Expand Search), fid decreased (Expand Search), _ decrease (Expand Search)
Showing 41 - 60 results of 17,213 for search '(( significant decrease risk ) OR ( significant ((bit decrease) OR (point decrease)) ))', query time: 0.27s Refine Results
  1. 41
    Baseline characteristics of patients.

    Baseline characteristics of patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 42
    Data for primary and sensitivity analysis.

    Data for primary and sensitivity analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 43
    Study design.

    Study design. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 44
    Odds ratios for each case period compared with the control period.

    Odds ratios for each case period compared with the control period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 45
    Sensitivity analysis of the group who had an exacerbation before the index date.

    Sensitivity analysis of the group who had an exacerbation before the index date. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 46
    Initial post-switch visits and SABA prescriptions in each period.

    Initial post-switch visits and SABA prescriptions in each period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 47
    Flow of eligible patients.

    Flow of eligible patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 48
    ICS/LABA before and after switch.

    ICS/LABA before and after switch. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 49
    Diseases excluded from the analysis.

    Diseases excluded from the analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 50
    Points of convergence / divergence between qualitative and quantitative findings.

    Points of convergence / divergence between qualitative and quantitative findings. by Emma Murphy (2270992)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 51
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 52
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 53
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 54
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 55
    Chemicals that decrease the expression levels of significant TWAS genes negatively associated with UF.

    Chemicals that decrease the expression levels of significant TWAS genes negatively associated with UF. by Gayeon Kim (671557)

    Published 2022
    Save to List
    Saved in:
  16. 56
    Sampling point (Source:

    Sampling point (Source: by Yonggang Huang (223155)

    Published 2025
    Save to List
    Saved in:
  17. 57
    The Laboratory Animal Flow Diagram.

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    <sup>1</sup>H NMR spectra for kylo-0603.

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    <sup>13</sup>C NMR spectra for Kylo-0603.

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    The structures of T3 and Kylo-0603.

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: